Once you have determined that amikacin is appropriate, what formulation of this antimicrobial do you consider? How do MOA and side effects differ between these options and does the MOA of liposome inhaled suspension confer advantages?

Once you have determined that amikacin is appropriate, what formulation of this antimicrobial do you consider? How do MOA and side effects differ between these options and does the MOA of liposome inhaled suspension confer advantages?

CLICK HERE FOR CME CREDIT

Once you have determined that amikacin is the appropriate intervention, what formulation of this antimicrobial do you consider? How do MOA and side effects differ between these options and does the MOA of liposome inhaled suspension confer advantages? 

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina